Loading...
Portfolio Diversification
Range
Most Diversified
31 instruments
August 19, 2025
Least Diversified
0 instruments
February 1, 2022
Average
29.3 instruments
Most Consistent Holdings
Top 5
JNJ97.82%
MRK97.82%
PFE97.82%
AMGN97.82%
ABBV97.82%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since February 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Bridgebio (BBIO) | 4.1% | 3.21% | 77.75% | - |
 Guardant Health (GH) | 3.89% | 4.11% | 97.82% | - |
 Eli Lilly (LLY) | 3.79% | 3.3% | 97.82% | - |
 Exact Sciences (EXAS) | 3.48% | 3.81% | 97.82% | - |
 Vertex (VRTX) | 3.33% | 0% | 93.11% | 12/29/2025 |
 Gilead Sciences (GILD) | 3.29% | 3.92% | 97.82% | - |
| Merck (MRK) | 3.23% | 3.47% | 97.82% | - |
| Johnson & Johnson (JNJ) | 3.22% | 3.63% | 97.82% | - |
| AbbVie (ABBV) | 3.14% | 3.15% | 97.82% | - |
| Amgen (AMGN) | 3.12% | 3.29% | 97.82% | - |
 Regeneron (REGN) | 3.12% | 3.26% | 97.54% | - |
 Bristol-Myers Squibb (BMY) | 2.96% | 3.24% | 97.61% | - |
 Illumina (ILMN) | 2.95% | 2.62% | 97.68% | - |
| Pfizer (PFE) | 2.9% | 3.48% | 97.82% | - |
 ImmunoGen Inc (IMGN) | 2.73% | 0% | 46.76% | 2/14/2024 |
 Exelixis (EXEL) | 2.68% | 2.49% | 73.52% | - |
 Revolution Medicines (RVMD) | 2.66% | 4.66% | 77.75% | - |
 Argenx (ARGX) | 2.5% | 2.67% | 77.47% | - |
 CRISPR Therapeutics (CRSP) | 2.38% | 0% | 68.19% | 12/26/2024 |
 Syndax (SNDX) | 2.31% | 3.92% | 77.75% | - |
 Blueprint Medicines (BPMC) | 2.07% | 0% | 62.39% | 7/23/2025 |
 Iovance (IOVA) | 2.05% | 0% | 72.97% | 12/29/2025 |
 Arcellx (ACLX) | 1.92% | 5.45% | 53.99% | - |
 AstraZeneca (AZN) | 1.69% | 2.98% | 53.99% | - |
 TG Therapeutics (TGTX) | 1.58% | 0% | 45.05% | 12/29/2025 |
 Mirati Therapeutics Inc (MRTX) | 1.38% | 0% | 45.8% | 1/31/2024 |
 BeiGene (ONC) | 1.35% | 2.71% | 48.53% | - |
 Zai Lab (ZLAB) | 1.33% | 0% | 48.53% | 12/29/2025 |
 SpringWorks Therapeutics (SWTX) | 1.32% | 0% | 37.27% | 7/3/2025 |
 BD (BDX) | 1.3% | 0% | 49.28% | 12/29/2025 |
 Crinetics (CRNX) | 1.24% | 0% | 33.24% | 12/29/2025 |
 Fate Therapeutics (FATE) | 1.09% | 0% | 43.82% | 1/2/2024 |
 Halozyme (HALO) | 1.03% | 2.77% | 29.62% | - |
 Seagen Inc (SGEN) | 1.01% | 0% | 22.73% | 12/18/2023 |
 Merus (MRUS) | 0.99% | 0% | 25.46% | 1/6/2026 |
 Scholar Rock (SRRK) | 0.98% | 4.18% | 29.62% | - |
 Legend Biotech (LEGN) | 0.84% | 0% | 23.75% | 1/2/2024 |
 Incyte (INCY) | 0.82% | 0% | 20.07% | 1/12/2023 |
 BioNTech SE (BNTX) | 0.76% | 0% | 20.07% | 1/12/2023 |
 2Seventy Bio (TSVT) | 0.76% | 0% | 20.07% | 1/12/2023 |
 Option Care Health (OPCH) | 0.75% | 0% | 24.37% | 12/26/2024 |
 Rocket (RCKT) | 0.69% | 0% | 24.37% | 12/26/2024 |
 Arvinas (ARVN) | 0.69% | 0% | 24.37% | 12/26/2024 |
 Agenus (AGEN) | 0.68% | 0% | 20.07% | 1/12/2023 |
 LabCorp (LH) | 0.67% | 0% | 20.07% | 1/12/2023 |
 Celldex (CLDX) | 0.64% | 3.04% | 28.46% | - |
 GlaxoSmithKline (GSK) | 0.62% | 0% | 20.07% | 1/12/2023 |
 MannKind (MNKD) | 0.62% | 0% | 23.75% | 1/2/2024 |
 Sorrento (SRNE) | 0.54% | 0% | 20.07% | 1/12/2023 |
 Inovio (INO) | 0.51% | 0% | 20.07% | 1/12/2023 |
 Clovis Oncology Inc (CLVSQ) | 0.46% | 0% | 18.7% | 12/22/2022 |
 Janux (JANX) | 0.43% | 0% | 24.91% | 12/29/2025 |
 Surface Oncology Inc (SURF) | 0.34% | 0% | 18.7% | 12/22/2022 |
 IDEAYA (IDYA) | 0.31% | 2.87% | 13.38% | - |
 Invitae Corp (NVTAQ) | 0.25% | 0% | 20.07% | 1/12/2023 |
 Curis (CRIS) | 0.23% | 0% | 18.7% | 12/22/2022 |
 Novocure (NVCR) | 0.21% | 0% | 8.81% | 12/29/2025 |
 Olema (OLMA) | 0.17% | 3.15% | 4.71% | - |
 Cogent Biosciences (COGT) | 0.16% | 3.38% | 4.71% | - |
 Nuvalent (NUVL) | 0.14% | 2.95% | 4.71% | - |
 Arcus Biosciences (RCUS) | 0.12% | 2.63% | 4.71% | - |
 Kura Oncology (KURA) | 0.12% | 2.95% | 4.16% | - |
 Zymeworks (ZYME) | 0.11% | 2.39% | 4.71% | - |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2026
| Instrument | Invested | Value |
|---|---|---|
| Guardant Health (GH) | 1.68% | 4.75% |
| Scholar Rock (SRRK) | 5.61% | 4.2% |
| Revolution Medicines (RVMD) | 1.73% | 3.89% |
| Bridgebio (BBIO) | 0.53% | 3.88% |
| Exact Sciences (EXAS) | 3.33% | 3.86% |
| Syndax (SNDX) | 5.26% | 3.85% |
| Olema (OLMA) | 5.06% | 3.77% |
| Eli Lilly (LLY) | 1.72% | 3.7% |
| Gilead Sciences (GILD) | 2.61% | 3.45% |
| Regeneron (REGN) | 3.95% | 3.42% |
| Cogent Biosciences (COGT) | 4.73% | 3.34% |
| Pfizer (PFE) | 5.63% | 3.31% |
| Merck (MRK) | 3.82% | 3.26% |
| AbbVie (ABBV) | 2.93% | 3.24% |
| Argenx (ARGX) | 2.09% | 3.22% |
| Johnson & Johnson (JNJ) | 3.36% | 3.22% |
| Arcellx (ACLX) | 3.82% | 3.21% |
| Merus (MRUS) | 1.93% | 3.1% |
| IDEAYA (IDYA) | 3.24% | 3.08% |
| Nuvalent (NUVL) | 4.1% | 3.08% |
| Amgen (AMGN) | 2.99% | 3.01% |
| Bristol-Myers Squibb (BMY) | 4.34% | 3% |
| AstraZeneca (AZN) | 2.82% | 2.92% |
| Arcus Biosciences (RCUS) | 3.66% | 2.91% |
| Celldex (CLDX) | 3.62% | 2.9% |
| Halozyme (HALO) | 2.65% | 2.85% |
| Illumina (ILMN) | 3.04% | 2.84% |
| BeiGene (ONC) | 3.75% | 2.82% |
| Exelixis (EXEL) | 1.82% | 2.71% |
| Zymeworks (ZYME) | 3.52% | 2.7% |
Cash & Instruments Over Time
Unlock Premium Features
Get access to this feature and many more with BullAware Pro.